Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00273845 · ClinicalTrials.gov registry record · Phase 2

Reducing Barriers to Drug Abuse Treatment Services

A Phase 2 study, sponsored by Wright State University.

Completed
Registry status
Phase 2
Development phase
678
Enrollment target

NCT00273845 is a Phase 2 study that has completed, run by Wright State University. The registered enrollment target is 678 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00273845, a Phase 2 study, has completed, sponsored by Wright State University.

COMPLETED
Registry status
Phase 2
Development phase
678 participants
Enrollment target

Study Summary

The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engagement" represents a more comprehensive conceptualization of "treatment retention" and includes measures of the clinical and ancillary services actually received by the client over time; as such, client engagement focuses on the intensity and duration of treatment participation. This study will enhance the CIU concept by conducting a controlled trial, using a three-armed research design, of interventions designed to enhance treatment linkage and treatment engagement. These interventions - a Motivational Intervention and Strengths-Based Case Management - are science-based and have demonstrated efficacy in moving drug abusers towards treatment and supporting treatment engagement.

Interventions

  • BEHAVIORAL Motivational interviewing
  • BEHAVIORAL Strengths-Based Case Management

Trial Details

FieldValue
Enrollment Target 678 participants
Start Date 2003-05
Est. Completion 2008-05
Phase Phase 2

Sponsor

Wright State University

32 total trials

What the Registry Record Tells You About NCT00273845

The ClinicalTrials.gov registry entry for NCT00273845 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wright State University, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Motivational interviewing is the first listed.

NCT00273845 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00273845 about?

NCT00273845 is a clinical study titled "Reducing Barriers to Drug Abuse Treatment Services". The broad goal of this study is to assess the effectiveness of two interventions to facilitate treatment linkage and treatment engagement. "Treatment linkage" is operationally defined as completion of agency intake procedures and attendance at the first clinical or therapy session. "Treatment engage...

What is the current status of trial NCT00273845?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 678 participants. The study started on 2003-05. Estimated completion is 2008-05.

What interventions are being tested in trial NCT00273845?

The interventions under investigation include: Motivational interviewing (BEHAVIORAL), Strengths-Based Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00273845?

This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.